speb/financial-data huggingface dataset:
DIACABS.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 202773000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 54848000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 202773000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 54848000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 530733846.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 510933333.00
DIACABS.NS income_statement (annual, 2025-03-31) — Diluted EPS: 0.65
DIACABS.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.15
DIACABS.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 344977000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 76640000.00
DIACABS.NS income_statement (annual, 2025-03-31) — EBIT: 470563000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — EBIT: 85070000.00
DIACABS.NS income_statement (annual, 2025-03-31) — EBITDA: 673336000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — EBITDA: 139918000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — End Cash Position: 136018000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -58855000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 294914000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 294914000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -505193000.00
DIACABS.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 150328000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 11536553000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 11536553000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 18489969000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 18489969000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Gross Profit: 1754514000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 475096000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Interest Expense: 126443000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 8609000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 126443000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 8609000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Interest Income: 2400000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 2400000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -123545000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Inventory: 2055298000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 2055298000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 14804769000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 14804769000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -687112000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 10744000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 10744000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 1031239000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 1031239000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 25950000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 25950000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 22241371000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 22241371000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 22267321000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 22267321000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 3234000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 3234000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 13420795000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 13420795000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Net Debt: 23519606000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 23519606000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Net Income: 344977000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Net Income: 76640000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 344977000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 76640000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 344977000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 76640000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 344977000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 76640000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 344977000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 76640000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 344120000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 344977000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 76640000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Net Interest Income: -126443000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -8609000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 0.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 70074000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 668081000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -126443000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -8609000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -2895000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -10376000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Net PPE: 13025102000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 13025102000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -676736000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -598007000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: -8786602000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -8786602000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 2015000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 2015000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 3234000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 3234000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 10744000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 10744000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 673336000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 139918000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Normalized Income: 344977000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 76640000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 171543000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Operating Income: 465006000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Operating Income: 82704000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Operating Revenue: 11153925000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 3338083000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 526971060.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 526971060.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Inside Changein Cash: 601703000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: 601704000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 881831000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 881831000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 42107000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 42107000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: -9313573000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: -9313573000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 410125000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 410125000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 126440000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 117000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 117000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: -2687000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: -2687000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 5557000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 2367000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 948766000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 294955000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Other Payable: 94998000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 94998000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Other Properties: 759105000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 759105000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 20425000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 20425000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 64253000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 64253000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Other Special Charges: -131000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Payables: 2106390000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Payables: 2106390000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 27573000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 27573000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 850090000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 850090000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Pretax Income: 344120000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 76461000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -676736000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 667542000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 667542000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 9399411000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2862987000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 202773000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 54848000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 3391000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 3391000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 64253000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 64253000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: -19966219000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -19966219000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 174978000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 325306000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Share Issued: 526971060.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 526971060.00
DIACABS.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: -8786602000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -8786602000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: -8786602000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -8786602000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
DIACABS.NS income_statement (annual, 2025-03-31) — Tax Provision: -857000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Tax Provision: -179000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.30
DIACABS.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
DIACABS.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 11316000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 11316000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Total Assets: 17871478000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 17871478000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 13454769000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 13454769000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Total Debt: 23619984000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 23619984000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: -8786602000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -8786602000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Total Expenses: 10688919000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 3255379000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 26658080000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 26658080000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 13042241000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 13042241000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 22268169000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 22268169000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 948000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 26603000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 26603000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
DIACABS.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Work In Process: 682717000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 682717000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Working Capital: 439324000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 439324000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 348559000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 3018229000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 529126316.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.38
DIACABS.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2433504000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 72976000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 72976000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 529126316.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.38
DIACABS.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 201068000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — EBIT: 238251000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — EBITDA: 311227000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 584725000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 36907000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 36907000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Net Income: 201068000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 201068000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 201068000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 201068000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 201068000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 201068000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -36907000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -36907000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 311227000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 201068000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Operating Income: 236166000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 3018229000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 2085000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 229521000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 201344000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2433504000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 72976000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 276000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 2782063000.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
DIACABS.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 434197000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 4383329000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1064083000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 2952647000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 21435000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 523166038.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 0.53
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 31631000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 526971000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 249274000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 315596000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 526971000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -7145464000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 1286654000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 3563944000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 7267270000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 2663000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 370348000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 373011000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 2898623000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 7180000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 73999000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 73999000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 523166038.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.53
DIACABS.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 277278000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — EBIT: 386232000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — EBITDA: 460231000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 13143347000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 819385000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 98177000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 98177000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 2795561000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: -1079354000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 21435000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 28968000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 5695762000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 5724730000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 4276000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 5816836000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Net Income: 277278000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 277278000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 277278000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 277278000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 277278000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 277278000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -98177000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -98177000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 13143347000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -7145464000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 2138000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 460231000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 277278000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Operating Income: 385188000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 4383329000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 526971060.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1203466000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1425648000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: -7672435000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 41364000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 1044000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 305653000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 11856693000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 66322000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Payables: 1064083000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 288055000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 3563944000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 73999000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 526971060.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -7145464000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -7145464000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 10777000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.04
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 20475553000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -1449702000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 6097741000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -7145464000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 3998141000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 27621017000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 13208284000.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 24722394000.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
DIACABS.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
DIACABS.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 4368647000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 489876000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 4740806000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 528932979.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.94
DIACABS.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 3638354000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 78608000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 78608000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 528932979.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.94
DIACABS.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 497197000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — EBIT: 618959000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — EBITDA: 697567000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 1102452000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 110984000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 110984000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Net Income: 497197000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 497197000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 497197000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 497197000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 497197000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 497197000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -110984000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -110984000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 697567000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 497197000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Operating Income: 612576000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 4740806000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 6383000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 339481000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 507975000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 3638354000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 78608000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 10778000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.02
DIACABS.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 4128230000.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
DIACABS.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
DIACABS.NS income_statement (annual, 2026-03-31) — +Operating Expense: 1875481000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 602849000.00
DIACABS.NS income_statement (annual, 2026-03-31) — +Total Revenue: 19101022000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 6958657000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 3506589000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 3506589000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 4642291000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 4642291000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 24606000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 24606000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 527085217.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 1.15
DIACABS.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 71765000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -812220000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 65069000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 65069000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 526971000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 526971000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 358076000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 358076000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1191062000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1191062000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -1637011000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -242559000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 113359000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Change In Payable: 1521800000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -2886203000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -3120552000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 286312000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Common Stock: 526971000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 526971000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: -6042037000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -6042037000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 1523234000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 1523234000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 15296411000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 5660610000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Current Assets: 10487248000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 10487248000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 13852000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 13852000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Current Debt: 423423000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 423423000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 437275000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 437275000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 5139602000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 5139602000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 33154000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 33154000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Depreciation: 307148000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 307148000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 307148000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 81565000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 307148000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 81565000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 527085217.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.15
DIACABS.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 1581693000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 606148000.00
DIACABS.NS income_statement (annual, 2026-03-31) — EBIT: 2009090000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — EBIT: 765648000.00
DIACABS.NS income_statement (annual, 2026-03-31) — EBITDA: 2316238000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — EBITDA: 847213000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — End Cash Position: 358077000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 1355315000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -1616532000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 6441000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 6441000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 13523736000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 13523736000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Gross Profit: 3804611000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 1298047000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Interest Expense: 389716000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 143649000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 389716000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 143649000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -383933000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Inventory: 3692308000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 3692308000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 19257908000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 19257908000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -1427653000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 24606000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 24606000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 51217000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 51217000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 24876522000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 24876522000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 24927739000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 24927739000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 10509000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 10509000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Net Debt: 24941869000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 24941869000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Net Income: 1581693000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Net Income: 606148000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 1581693000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 606148000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 1581693000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 606149000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1581693000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 606148000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1581693000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 606148000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 1619374000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 1581693000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 606149000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Net Interest Income: -389716000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -143649000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 0.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 1708575000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 2306394000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -389716000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -143649000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -5783000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -615433000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Net PPE: 13523736000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 13523736000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -812220000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -597819000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: -6048478000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -6048478000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: -5936000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: -5936000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 2316238000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 847213000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Normalized Income: 1581693000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 606148000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: -804312000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Operating Income: 1929130000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Operating Income: 695198000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Operating Revenue: 19101022000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 6958657000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 526971060.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 526971060.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Other Cash Adjustment Inside Changein Cash: 1162962000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 961587000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 961587000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 1101883000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1101883000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: -6569008000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: -6569008000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 389716000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 79961000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 70449000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 1329194000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 454539000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Other Properties: 12000502000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 12000502000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 832986000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 832986000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Payables: 3506589000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Payables: 3506589000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Pretax Income: 1619374000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 621999000.00
DIACABS.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -812220000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 15296411000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 5660610000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 307148000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 81565000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Share Issued: 526971060.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 526971060.00
DIACABS.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: -6042037000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -6042037000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: -6048478000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -6048478000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
DIACABS.NS income_statement (annual, 2026-03-31) — Tax Provision: 37681000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 15850000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.02
DIACABS.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.03
DIACABS.NS balance_sheet (annual, 2026-03-31) — Total Assets: 24036095000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 24036095000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 18834485000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 18834485000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Total Debt: 25365014000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 25365014000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: -6042037000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -6042037000.00
DIACABS.NS income_statement (annual, 2026-03-31) — Total Expenses: 17171892000.00
DIACABS.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 6263459000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 30078132000.00
DIACABS.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 30078132000.00
DIACABS.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 13548847000.00